Dawei Huo

机构：Tangshan College, Huawei Technologies (China), Cell Technology (China), Shanghai Electric (China), First Affiliated Hospital Zhejiang University, Changsha University of Science and Technology, Zhejiang University · ORCID：0000-0002-6144-7063

发表论文 52 篇 · 总被引 888 次 · h-index 15

代表论文

• Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial (2025 · Nature Medicine · 被引 55)
• Exosome‐Mediated Lectin Pathway and Resistin‐MIF‐AA Metabolism Axis Drive Immune Dysfunction in Immune Thrombocytopenia (2025 · Advanced Science · 被引 14)
• Non-canonical PRC1.1 licenses transcriptional response to enable Treg plasticity in immune adaptation (2025 · Molecular Cell · 被引 9)
• The Ets2 super-enhancer modulates endothelial-mesenchymal transition during cardiac ageing (2025 · Cardiovascular Research · 被引 3)
• Targeting the SP/KLF Transcriptional Regulatory Network Synergizes with HDAC Inhibition to Impede Progression of H3K27M Diffuse Intrinsic Pontine Glioma (2025 · Cancer Research · 被引 3)
• Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacy (2026 · Nature Cancer · 被引 2)